Global Sensitivity Analysis of Whole-Body Physiologically Based Pharmacokinetic Model Parameters in [ 177 Lu]Lu-PSMA-I&T Radioligand Therapy: Key Determinants of Individual Kidney and Tumor Absorbed Dose Uncertainty and Implications for Digital Twin Development